FDA Updates Informed Consent Guideline to Ensure Participation Is Voluntary

Clinical Trials Advisor
A A
Sponsors designing clinical trials that involve certain vulnerable patient populations will soon face greater scrutiny from institutional review boards, under newly issued FDA guidance.

To View This Article:

Login

Subscribe To Clinical Trials Advisor

Buy This Article Now

Add this article to your cart for $25.00